Background. The purpose of this study was to investigate the prevalence of skeletal muscle atrophy and its relation to exercise intolerance and abnormal muscle metabolism in patients with heart failure (HF).
Ex xertional fatigue is a major limiting symptom in patients with heart failure. Traditionally, this fatigue has been attributed to skeletal muscle underperfusion. However, recent studies have demonstrated that patients with heart failure also exhibit intrinsic skeletal muscle changes, including fiber atrophy, a reduction in lipolytic and oxidative enzymes, and altered metabolic responses to exercise as assessed with 31P magnetic resonance spectroscopy (MRS).1-5 These skeletal muscle alterations may contribute to exertional fatigue in heart failure. Muscle atrophy may be a particularly important factor as muscle mass is a determinant of exercise capacity in normal subjects. 6 The purpose of the present study was to investigate the contribution of skeletal muscle atrophy to exertional fatigue and altered muscle metabolism in heart failure. We examined the prevalence of skeletal muscle atrophy in a large group of ambulatory patients with heart failure by using standard anthropometric measurements and magnetic resonance imaging (MRI) of leg muscles. Indexes of muscle mass were then correlated with maximal exercise capacity.
We also sought to test the hypothesis that muscle atrophy contributes to skeletal muscle metabolic abnormalities in heart failure. Altered forearm and calf metabolic responses to exercise have been demonstrated previously using 31P MRS.7-10 These metabolic abnormalities may result from muscle atrophy. When faced with a given external load, muscle that is atrophied would be subjected to a greater work load per remaining fiber than normal muscle and would therefore develop greater reductions in phosphocreatine (PCr) and intracellular pH.
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To investigate this hypothesis, MRI and spectroscopy of the calf were performed in normal subjects and patients with heart failure. The metabolic response to exercise expressed as the work slope was correlated with indexes of muscle mass. Another index of oxidative metabolism, i.e., the time constant of recovery of phosphocreatine after submaximal work, was also measured. The time constant is independent of work intensity and muscle mass."1,2 Therefore, demonstration of comparable time constants in the two groups would further support the hypothesis that the metabolic abnormalities noted in patients with heart failure are primarily due to muscle atrophy. Conversely, demonstration of an abnormal time constant in the patients would indicate that intrinsic muscle changes, such as a reduction in mitochondrial oxidative capacity, contribute to the metabolic abnormalities.
Methods

Subjects
A total of 76 patients were studied. Seventy-one patients were men, and five were women. The average± SD age was 59±10 years. Six percent of patients had New York Heart Association functional class I, 29% had class II, 59% had class III, and 6% had class IV heart failure symptomatology. Etiology of heart failure was coronary artery disease in 41% of patients, idiopathic dilated cardiomyopathy in 26%, alcoholic cardiomyopathy in 19%, valvular heart disease in 6%, and hypertensive cardiomyopathy in 8%. Ejection fraction averaged 22+11%. Peak exercise oxygen consumption was 13.6±4.0 ml/kg/min (range, 4.0-20.7 ml/kg/min). All patients were receiving therapy with digoxin and diuretics. Patients with alcoholic cardiomyopathy were abstinent from alcohol for at least 6 months. Seven patients were not receiving vasodilators. Forty-one were receiving angiotensin converting enzyme inhibitors, and 14 were receiving hydralazine and/or nitrates. Eight patients had peripheral edema.
For the MRS studies, 10 normal subjects were recruited; the average±SD age was 51±9 years. Peak Vo2 was 33±9 ml/kg/min.
Sixty-two patients underwent anthropomorphic assessment, 32 patients completed dietary histories, and 15 patients participated in magnetic resonance studies. One patient participated in both anthropomorphic and magnetic resonance protocols. There were no statistical differences between the groups in regard to age, gender, ejection fraction, or exercise capacity ( Table 1) .
The study was approved by the Committee on Studies Involving Human Beings at the University of Pennsylvania, and written informed consent was obtained from all subjects.
All patients underwent maximal treadmill exercise using the modified Naughton protocol with measurement of oxygen consumption (SensorMedics). Normal subjects underwent maximal treadmill exercise using the Bruce protocol with measurement of oxygen consumption. Exercise was limited by dyspnea and/or fatigue in all subjects. Patients limited by chest pain or claudication were excluded.
Anthropometric assessment and dietary history. Sixtytwo patients underwent anthropometric evaluation. Height, body weight, and wrist circumference were measured. Percent ideal body weight was derived from actual weight divided by ideal body weight as estimated from standard Metropolitan Life tables adjusted for height and body frame size. 13 Triceps skinfold thickness of the nondominant arm was measured using Lange calipers (Cambridge Scientific Instruments, Cambridge, Md.). Each skinfold measurement was estimated to the nearest 1 mm, and the mean was calculated from three readings. Midarm circumference of the nondominant arm was also measured. Midarm muscle circumference was derived from the formula C-7r S, and midarm muscle area was derived from (C-7rS)2/47r, where C is midarm circumference and S is triceps skinfold. [13] [14] [15] [16] Twenty-four-hour urine collection was performed on an outpatient basis. Specimens were then analyzed for creatinine. Urine collections containing a volume of less than 1,000 ml or less than 1 g creatinine were repeated. Creatinine/height index was calculated from 24- 
3`P MRS Measurements
Two methods were used to assess an individual's metabolic response to exercise: the inorganic phosphorus (Pi)-to-PCr ratio correlated with power output (work slope) and the calculation of the time constant of PCr recovery.
The Pi-to-PCr ratio provides an estimate of ADP concentration. ADP level is closely linked to mitochondrial respiration. Thus, the Pi-to-PCr ratio provides an index of oxidative metabolism. As described in the transfer function of Chance et al,2324 the relation during low-level exercise between power output and the Pi-toPCr ratio is linear. Therefore, the calculation of the slope of this relation affords a simple way of comparing oxidative metabolism between subjects.
Another method for comparing oxidative metabolism between subjects is the calculation of the time constant of recovery for phosphocreatine. At the beginning of any work load, ATP use and production are accelerated by the production of ADP. At the cessation of work, ATP use stops, but accelerated production continues.
Thus, the rate of oxidative metabolism can be indirectly assessed by monitoring the rate of recovery of PCr, which is proportional to ADP after termination of work. A major advantage of measurement of PCr recovery rate is that it is independent of work level. In human subjects, it is difficult during work to control muscle recruitment and to normalize for muscle mass. The recovery constant provides an index of oxidative metabolism independent of these factors. '1'225 -28 To assess calf metabolism, all subjects were placed in a supine position in a 1.8-T, 1-m bore superconducting magnet (Oxford Research Systems, Oxford, England) with the gastrocnemius muscle positioned over an 8-cm surface coil. Data acquisition was accomplished with the application of radiofrequency pulses (pulse width optimized at 25-35 msec) applied every 4 seconds. After optimization of field homogeneity, 1-minute scans were recorded during rest and incremental exercise. During the recovery phase, 8-second spectra were obtained. In some subjects with fast recovery rates, data were collected as 4-second spectra.
The exercise protocol consisted of supine plantarflexion of the foot. The subject's foot was placed on a pedal ( Figure 1 ) attached via a pulley system to a variable number of elastic bands. A system of Velcro straps was used at the knee, ankle, waist, and shoulders to immobilize the body. Work loads were of 4 minutes' duration and were continuous. The initial work load was extension of one elastic band via plantar flexion every 8 seconds. This was followed by extension of one elastic band every 4 seconds. All subsequent work loads were at a frequency of plantar flexion every 4 seconds with increasing numbers of elastic bands. The maximum work load was extension of four elastic bands every 4 seconds.
After completion of the ramp exercise protocol, the subjects rested for 15 minutes. During that interval, the work level that resulted in a Pi-to-PCr ratio of approximately 0.7 was identified by review of the exercise scans. This work level was then selected for the performance of the recovery test. A 2-minute rest scan was obtained to ensure full metabolic recovery. Three minutes of exercise were performed. Seven minutes of recovery scans were then collected.
To quantitate work performed, force and distance were measured. The force required to extend the elastic bands was determined by the suspension of known weights from each band. During exercise, the distance and duration the pedal was depressed were monitored using a mercury-inSilastic strain gauge connected in parallel with the pulley system. Before exercise, the pedal was fully depressed; this corresponded to 6 cm of band extension. Subsequent deflections produced during exercise were compared with the full deflection. Average power was derived from the following equation: 
Results
Anthropomorphic Measurements
The data for anthropomorphic measurements and serum chemistries are summarized in Table 2 . The distribution curves for triceps skinfold, creatinine/ height index, and arm muscle circumference are depicted in Figure 2 .
To determine the incidence of muscle atrophy in the patients, we divided the patients according to arm muscle circumference and creatinine height index. An arm muscle circumference of >50% is considered normal, whereas <5% is consistent considerable muscle atrophy. Similarly, a creatinine height index of <7.4 mg/cm is consistent with severe protein energy starvation. With this approach, 68% of our patients exhibited evidence of severe muscle atrophy. When patients were stratified by exercise capacity using the classification of Weber,33 similar frequencies of atrophy were observed in patients with mild, moderate, or severe exertional intolerance (Figure 2 ). This atrophy was not usually associated with inadequate protein synthetic function or loss of fat stores. Only 24% of patients exhibited serum albumin of <3.5 mg/dl, prealbumin of <20 mg/dl, and/or transferrin of <180 mg/dl. Similarly, fat stores assessed using triceps skinfold measurements that were <5% standard and/or using percent ideal body weights that were <80% were reduced in only 8% of patients.
To investigate the relation between muscle mass and maximal exercise performance, peak exercise Vo2 was correlated with all parameters of muscle mass. Modest linear correlations were observed between peak Vo2 and calf muscle volume normalized for body surface area, midarm circumference, muscle circumference, muscle area, creatinine height index, and skeletal muscle mass derived from the 24-hour urinary creatinine (Table 3) . No significant linear correlations were observed between peak Vo2 and lean body mass, weight, or triceps skinfold (r<0.25, p=NS for all).
The impact of varying medical regimens on anthropomorphic measurements was also assessed. No differences in percent ideal body weight, creatine/height 
3`P MRS Measurements
Work slope. Supine plantar flexion against an increasing force resulted in a progressive increase in the Pi-to-PCr ratio in both normal subjects and patients with heart failure. Representative 31P MRS spectra at rest and during exercise in a normal and a heart failure subject are depicted in Figure 3 . A rapid depletion of PCr and reduction in intracellular pH are illustrated in the spectra from the patient with heart failure.
The work slope was significantly greater in patients with heart failure than in control subjects (controls, Because the resolution of the images was insufficient to provide determination of isolated gastrocnemius muscle volume, total calf muscle volume was measured. Analysis was also performed using the largest muscle cross-sectional area that corresponded to the approximate site where scanning was performed; this provided another index of muscle mass.
Calf muscle volume was significantly reduced in patients with heart failure compared with normal subjects (controls, 1,299+286 cm3; HF, 1,051±295 cm3; p<0.05).
When muscle volume was normalized for body surface area, this difference remained significant (controls, 675±84 cm3/m2; HF, 567±112 cm3/m2; p<O.Ol). Representative images of a heart failure and a normal subject are depicted in Figure 4 . Fatty infiltration was noted in many of the heart failure subjects.
Linear regression analysis was performed using the work slope relation and muscle volume ( Figure 5) magnetic resonance spectroscopy spectra in a normal slkbject and a patient with heart failure (CHF) at rest and with exercise.
P,, inorganic phosphorus; PCr, phosphocreatine; ATP, adenosine triphosphate.
(r= -0.42, p<0.05). However, no significant correlation was observed between the work slope and largest calf muscle cross-sectional area (r<-0.3,p=NS). The work slope was also normalized for muscle area. In each subject, work loads were divided by the largest muscle cross-sectional area. Work loads expressed as watts per centimeter squared were then correlated with power output. If muscle mass were the predominant variable responsible for the statistically different work slopes between normal and heart failure subjects, then the normalized work slopes should be comparable in the two groups. In fact, the normalized work slopes remained statistically different (controls, 0.11±0.09 cm2/W; HF, 0.05 +0.04 cm2/W; p<0.05).
Recovery data. Recovery data were inadequate in two normal subjects and one patient with heart failure due to insufficient PCr depletion. For heart failure and normal subjects at the end of exercise, Pi-to-PCr ratio (controls, 0.69+0.22; HF, 0.73±0.35;p=NS) and intracellular pH (controls, 6.97±0.07; HF, 6.96±0.07; p=NS) were similar. PCr recovery curves were well fitted by a single exponential and are illustrated in Figure 6 . The PCr time constants were significantly increased in patients with heart failure; they ranged from 38.8 to 259 seconds with a mean of 82.0±60.5 seconds versus from 14.8 to 51.1 seconds with a mean of 40.4±11.3 seconds in the normal subjects (p<0.05). Vm,,, was significantly reduced in heart failure subjects and ranged from 7.4 to 38.9 mM/kg/min with a mean of 25.4±10.2 mM/kg/min versus 30.5 to 88.8 mM/kg/min with a mean of 43.8±19.0 mM/kg/min in the normal subjects (p<0.05).
A positive linear correlation was observed between the work slope and the time constant of recovery for all subjects (r=0.73, p<0.0001). However, there was no significant correlation between MRI determined muscle volume and the time constant of recovery (r= -0.40,p=NS). The recovery constant did not correlate with peak Vo2 in patients with heart failure (r= -0.26,p=NS) or in normal subjects (r=-0.40, p=NS) but did correlate with the entire group (r= -0.43, p<0.05).
Discussion
The development of skeletal muscle atrophy in patients with severe heart failure is well documented. Hippocrates initially described this condition: "The flesh is consumed and becomes water . . . the abdomen fills with water; the feet and legs swell; the shoulders, clavicles, chest, and thighs melt away."34'35 More recently, several investigators described severe muscle atrophy and malnutrition in patients with heart failure and related this abnormality to poor outcomes during cardiac surgery.36-38 Carr et a139 examined the incidence of malnutrition in 48 patients with severe heart failure undergoing intensive medical therapy and/or cardiac transplant evaluation. These investigators noted malnutrition in 50% of the patients, as defined by a decrease in percent body fat determined from skinfold thickness, a decreased weight-to-height index, or reduced serum albumin; muscle volume was not reported but was probably reduced.
The present study confirms that atrophy occurs in patients with severe heart failure and further demon- In normal subjects, the amount of muscle is an important determinant of exercise capacity. 6 In younger populations, muscle mass correlates with maximal exercise capacity.6 In women, the reduced peak aerobic capacity compared with that in men is in part due to smaller muscle mass. 46 In aged and/or deconditioned populations, loss of muscle mass appears to limit exercise capacity.47,48 Accordingly, muscle atrophy could be an important and potentially reversible contributor to exercise intolerance in patients with heart failure.
To investigate whether the skeletal muscle atrophy observed in our patients contributed to their exercise intolerance, we examined the relation between muscle mass and both peak exercise Vo2 and muscle metabolic behavior, as assessed by 31p MRS. Peak Vo2 provides an index of a patient's overall functional capacity. 33 Muscle metabolic behavior provides insight into the metabolic changes that ultimately produce muscle fatigue.
Modest but significant correlations were noted between peak exercise Vo2 and a variety of parameters of muscle mass derived from anthropomorphic measurements, urinary creatinine, and MRI data. These correlations (r) ranged from 0.29 to 0.48, which is consistent with a modest contribution of muscle atrophy to exercise intolerance in patients.
In previous 31P MRS studies in patients with heart failure, premature muscle fatigue was noted during isolated forearm and calf exercise. This fatigue was associated with increased PCr depletion and lower intracellular pH levels than in normal subjects.7-10 We hypothesized that these metabolic changes may be due at least in part to muscle atrophy. When subjected to the same external work load, muscle fibers in atrophied muscle would experience greater work loads and, consequently, greater metabolic changes. To test this hypothesis, we correlated the calf work slope, a measure of oxidative capacity, with calf muscle volume, as assessed with MRI. We postulated that these variables should be related if atrophy contributed to the altered work slope. irt Failure FIGURE 6. Phosphocreatine recovery curves after exercise in a normal and a heart failure subject.
The values ofphosphocreatine con- prior history of significant alcohol use. In these patients, the prior toxic effect of alcohol on muscle may have contributed to the observed muscle atrophy. However, analysis of the data without this subgroup indicates a high prevalence of atrophy in all patients with heart failure.
In conclusion, our findings demonstrate significant skeletal muscle atrophy in patients with heart failure and suggest that this atrophy contributes modestly to the exercise intolerance and muscle metabolic abnormalities observed in such patients. It is likely that treating this muscle atrophy would improve to some extent the exercise capacity of patients with heart failure. Further efforts to identify the mechanism responsible for the muscle atrophy and to define methods of treating the atrophy are therefore warranted. However, the degree to which atrophy contributes to exercise intolerance in heart failure appears to be small, suggesting that increases in muscle mass will produce only modest improvements in exercise capacity.
